Carol A. Pollock - Concepedia

Author

Carol A. Pollock

Also Known As

C A Pollock, C Pollock, C. A. POLLOCK, C. A. Pollock, C. Pollock, C.A. Pollock, CAROL A POLLOCK, CAROL A. POLLOCK, CAROL POLLOCK, Carol A POLLOCK

639

Publications

27.1K

Citations

H-Index

248

Concepts

All Affiliations

The University of Sydney Royal North Shore Hospital UNSW Sydney University of Technology Sydney Concord Repatriation General Hospital

About

Carol A. Pollock is an author at The University of Sydney specializing in medicine, nephrology, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	52	108	8.3K
2	Health Sciences	16	17	1.1K
3	Education	4	4	120
4	Natural Sciences	3	3	228
5	Engineering	2	2	109

Carol A. Pollock

228

Publications

21.5K

Citations

H-Index

Page 1

	Year	Citations
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy Vlado Perkovic, Meg Jardine, Bruce Neal, New England Journal of Medicine	2019	5.7K
A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis Bruce A. Cooper, Pauline Branley, Liliana Bulfone, New England Journal of Medicine	2010	848
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress, The Lancet UrologyRenal DiseaseRenal EventsRenal FunctionDiabetes	2019	589
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference Iain C. Macdougall, Andreas J. Bircher, Kai‐Uwe Eckardt, Kidney International	2016	468
Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Christopher T. Chan, Peter J. Blankestijn, Laura M. Dember, Kidney International HemodialysisRenal DiseaseHealth PolicyMedicineGlobal Health	2019	404
The influence of dialysis treatment modality on the decline of remaining renal function. Michael J. Lysaght, Edward F. Vonesh, Frank A. Gotch, PubMed GlomerulonephritisHemodialysisUrologyRenal DiseaseHypertension	1992	298
Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey Nicole Evangelidis, Allison Tong, Braden Manns, American Journal of Kidney Diseases HemodialysisHealth PolicyMedicineClinical EndpointKidney Failure	2017	289
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups Kenneth W. Mahaffey, Meg Jardine, Séverine Bompoint, Circulation	2019	280
Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells—Renoprotection in Diabetic Nephropathy? Usha Panchapakesan, Kate Pegg, Simon Gross, PLoS ONE Renal PathologyImmunologyRenal InflammationInsulin SignalingInflammation	2013	273
Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Jennifer E. Flythe, Tara I. Chang, Martin Gallagher, Kidney International	2020	240

Page 1